{"id":"NCT00627523","sponsor":"Pfizer","briefTitle":"Genotropin Treatment In Very Young Children Born Small For Gestational Age","officialTitle":"A Two Year Multicentre, Randomized Two Arm Study Of Genotropin Treatment In Very Young Children Born Small For Gestational Age: Early Growth And Neurodevelopment(Egn)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-02","primaryCompletion":"2013-12","completion":"2013-12","firstPosted":"2008-03-03","resultsPosted":"2014-09-18","lastUpdate":"2014-11-04"},"enrollment":43,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Infant, Small for Gestational Age"],"interventions":[{"type":"DRUG","name":"Genotropin (PN-180,307) Somatropin","otherNames":[]},{"type":"DRUG","name":"Control-no treatment","otherNames":[]}],"arms":[{"label":"Active","type":"EXPERIMENTAL"},{"label":"Control","type":"EXPERIMENTAL"}],"summary":"To demonstrate the effect on height and psychomotor development of Growth Hormone treatment in very young children starting at an age of 2 years.","primaryOutcome":{"measure":"Change From Baseline in Height Standard Deviation Score (SDS) at Month 24.","timeFrame":"Baseline and Month 24","effectByArm":[{"arm":"GenotropinÂ®","deltaMin":1.63,"sd":0.13},{"arm":"Control","deltaMin":0.43,"sd":0.13}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"19 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":17,"countries":["Belgium","Czechia","France","Germany","Italy","Netherlands","Spain","Sweden","Switzerland"]},"refs":{"pmids":["26501737"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A6281287&StudyName=Genotropin%20Treatment%20In%20Very%20Young%20Children%20Born%20Small%20For%20Gestational%20Age"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":21},"commonTop":["Nasopharyngitis","Pyrexia","Bronchitis","Upper respiratory tract infection","Vomiting"]}}